v3.26.1
Consolidated Statements of Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common shares
Additional  Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2024   174,661,943      
Beginning balance, value at Dec. 31, 2024 $ 2,389,611 $ 1,740 $ 1,945,261 $ 1,236,696 $ (794,086)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common shares on exercise of options (in shares)   95,920      
Issuance of common shares on exercise of options (Note 15) 4,072 $ 1 4,071    
Issuance of common shares under the employee stock purchase plan (in shares)   121,936      
Issuance of common shares under the employee stock purchase plan (Note 15) 5,273 $ 1 5,272    
Net settlement on vesting of restricted share unit (in shares)   545,826      
Net settlement on vesting of restricted share units (Note 15) (13,461) $ 5 (13,466)    
Net settlement on vesting of performance units (in shares)   737,027      
Net settlement on vesting of performance units (Note 15) $ (17,999) $ 7 (18,006)    
Stock repurchased and retired (in shares) (1,898,010) (1,898,010)      
Stock repurchased and retired (Note 16) $ (92,961) $ (19)   (92,942)  
Expenses and taxes related to stock repurchased (Note 16) (538)     (538)  
Stock-based compensation expense (Note 15) 41,834   41,834    
Comprehensive income (loss):          
Net income 263,569     263,569  
Other comprehensive income (loss) 66,619       66,619
Dividend (59,408)     (59,408)  
End balance (in shares) at Jun. 30, 2025   174,264,642      
End balance, value at Jun. 30, 2025 2,586,611 $ 1,735 1,964,966 1,347,377 (727,467)
Beginning balance (in shares) at Mar. 31, 2025   174,870,928      
Beginning balance, value at Mar. 31, 2025 2,453,061 $ 1,742 1,941,478 1,274,790 (764,949)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common shares under the employee stock purchase plan (in shares)   61,991      
Issuance of common shares under the employee stock purchase plan (Note 15) 2,402 $ 0 2,402    
Net settlement on vesting of restricted share unit (in shares)   22,921      
Net settlement on vesting of restricted share units (Note 15) (712)   (712)    
Net settlement on vesting of performance units (Note 15) 0        
Stock repurchased and retired (in shares)   (691,198)      
Stock repurchased and retired (Note 16) (29,998) $ (7)   (29,991)  
Expenses and taxes related to stock repurchased (Note 16) (514)     (514)  
Stock-based compensation expense (Note 15) 21,798   21,798    
Comprehensive income (loss):          
Net income 132,716     132,716  
Other comprehensive income (loss) 37,482       37,482
Dividend (29,624)     (29,624)  
End balance (in shares) at Jun. 30, 2025   174,264,642      
End balance, value at Jun. 30, 2025 $ 2,586,611 $ 1,735 1,964,966 1,347,377 (727,467)
Beginning balance (in shares) at Dec. 31, 2025 170,341,479 170,341,479      
Beginning balance, value at Dec. 31, 2025 $ 2,549,401 $ 1,696 2,018,985 1,390,164 (861,444)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common shares on exercise of options (in shares) 2,800 2,800      
Issuance of common shares on exercise of options (Note 15) $ 77 $ 0 77    
Issuance of common shares under the employee stock purchase plan (in shares)   154,214      
Issuance of common shares under the employee stock purchase plan (Note 15) 5,041 $ 2 5,039    
Net settlement on vesting of restricted share unit (in shares)   642,433      
Net settlement on vesting of restricted share units (Note 15) (16,455) $ 6 (16,461)    
Net settlement on vesting of performance units (in shares)   260,106      
Net settlement on vesting of performance units (Note 15) $ (6,141) $ 3 (6,144)    
Stock repurchased and retired (in shares) (3,372,227) (3,372,227)      
Stock repurchased and retired (Note 16) $ (119,940) $ (34)   (119,906)  
Expenses and taxes related to stock repurchased (Note 16) (67)     (67)  
Stock-based compensation expense (Note 15) 48,632   48,632    
Comprehensive income (loss):          
Net income 293,729     293,729  
Other comprehensive income (loss) (86,155)       (86,155)
Dividend $ (63,325)     (63,325)  
End balance (in shares) at Jun. 30, 2026 168,028,805 168,028,805      
End balance, value at Jun. 30, 2026 $ 2,604,797 $ 1,673 2,050,128 1,500,595 (947,599)
Beginning balance (in shares) at Mar. 31, 2026   169,504,186      
Beginning balance, value at Mar. 31, 2026 2,475,193 $ 1,688 2,021,588 1,436,409 (984,492)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common shares on exercise of options (in shares)   0      
Issuance of common shares on exercise of options (Note 15) 0 $ 0 0    
Issuance of common shares under the employee stock purchase plan (in shares)   77,535      
Issuance of common shares under the employee stock purchase plan (Note 15) 2,300 $ 1 2,299    
Net settlement on vesting of restricted share unit (in shares)   7,011      
Net settlement on vesting of restricted share units (Note 15) (118) $ 0 (118)    
Net settlement on vesting of performance units (in shares)   314      
Net settlement on vesting of performance units (Note 15) 0 $ 0 0    
Stock repurchased and retired (in shares)   (1,560,241)      
Stock repurchased and retired (Note 16) (49,984) $ (16)   (49,968)  
Expenses and taxes related to stock repurchased (Note 16) (31)     (31)  
Stock-based compensation expense (Note 15) 26,359   26,359    
Comprehensive income (loss):          
Net income 145,737     145,737  
Other comprehensive income (loss) 36,893       36,893
Dividend $ (31,552)     (31,552)  
End balance (in shares) at Jun. 30, 2026 168,028,805 168,028,805      
End balance, value at Jun. 30, 2026 $ 2,604,797 $ 1,673 $ 2,050,128 $ 1,500,595 $ (947,599)